Comparing the current results to its competitors, Globus Medical Inc reported Revenue increase in the 2 quarter 2026 by 5.94 % year on year. The revenue growth was below Globus Medical Inc 's competitors' average revenue growth of 7.87 %, achieved in the same quarter.
Globus Medical Inc 's Comment on Competition and Industry Peers
The company identifies its primary competitors as Medtronic, DePuy Synthes, Stryker, Zimmer Biomet, and Smith + Nephew. Additional competitors include Alphatec Holdings, Orthofix, Integra LifeSciences, ZimVie, VB Spine, Boston Scientific, and other smaller public and private companies. These competitors may develop alternative treatments, products, or procedures for musculoskeletal disorders that compete directly or indirectly. They may also obtain patents or regulatory approvals more rapidly. The company also competes in recruiting qualified personnel and acquiring complementary technologies or licenses.
October 2, 2024
In a significant stride forward in the field of musculoskeletal health, Globus Medical, Inc. (NYSE: GMED), a leading innovator in orthopedic solutions, has announced the expansion of its already comprehensive orthopedic trauma product lineup. The latest announcement, dated October 2, 2024, signals a pivotal growth phase for the company as it reaffirms its commitment to providing cutting-edge solutions in orthopedic trauma care.This expansion is not just about increasing the product offerings; it represents a strategic move aimed at further establishing Globus Medical s position as a leader in orthopedic innovation, design, and functionality. By enriching its portfolio, the company is addressing the evolving ...
July 17, 2024
Globus Medical, a prominent company specializing in musculoskeletal solutions, has recently achieved a significant milestone in enhancing surgical precision and flexibility. The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Globus Medical s ExcelsiusFlex robotic navigation platform, specifically for Total Knee Arthroplasty (TKA) application. This cutting-edge technology is designed to empower surgeons with unprecedented control, exceptional resection accuracy, and procedural adaptability. Furthermore, Globus Medical s ACTIFY 3D Total Knee System, a state-of-the-art implant technology, has also received FDA clearance, further augmenting the capabilities of ExcelsiusFlex.The Excelsius...
SiBone Inc's business model revolves around the development and commercialization of innovative medical devices for the treatment of musculoskeletal disorders, particularly focused on the utilization of their patented iFuse Implant System.
Vicarious Surgical Inc utilizes a business model that combines robotics and virtual reality to revolutionize surgical procedures. Their technology allows surgeons to perform minimally invasive surgeries with precision and control using robotic arms guided by a virtual reality interface. By offering an innovative solution to traditional surgical methods, Vicarious Surgical aims to enhance patient outcomes while minimizing the invasiveness and risks associated with traditional procedures.
Procept Biorobotics Corporation follows a business model focused on developing medical robotics solutions for urology procedures. Their flagship product, the AquaBeam System, utilizes waterjet technology to perform minimally invasive surgeries for patients with benign prostatic hyperplasia. The company aims to improve patient outcomes and reduce healthcare costs by providing an innovative and efficient alternative to traditional surgical methods.
Orthofix Medical Inc is a company that focuses on developing and selling medical devices and orthopedic solutions to healthcare providers and patients.
Sources:
Globus Medical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Globus Medical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
